Literature DB >> 15313940

Chronic inflammation and impaired coronary vasoreactivity in patients with coronary risk factors.

Thomas H Schindler1, Egbert U Nitzsche, Manfred Olschewski, Nobuhisa Magosaki, Michael Mix, John O Prior, Alvaro D Facta, Ulrich Solzbach, Hanjoerg Just, Heinrich R Schelbert.   

Abstract

BACKGROUND: The goal of this study was to examine a possible association between systemic microinflammation, as reflected by C-reactive protein (CRP) serum levels, and coronary vasomotion in patients with coronary risk factors but with angiographically normal coronary arteries. METHODS AND
RESULTS: Coronary vasomotor function was studied in response to cold pressor testing (CPT) in 71 patients with normal angiograms. In all patients, CPT-induced changes in epicardial luminal area (LA; mm2) were assessed with quantitative angiography. Within 20 days, myocardial blood flow (MBF) responses to CPT were measured (mL x g(-1) x min(-1)) noninvasively with 13N-ammonia and PET imaging. The CPT-induced mean changes in LA and in MBF in patients with elevated CRP (> or =0.5 mg/dL) were significantly impaired compared with patients presenting with CRP levels within normal range (<0.5 mg/dL) (DeltaLA, -1.09+/-0.86 versus 0.45+/-0.63 mm2; DeltaMBF, 0.06+/-0.18 versus 0.44+/-0.31 mL x g(-1) x min(-1); P<0.0001, respectively). Coronary LA changes and MBF responses to CPT were inversely correlated with CRP serum levels (r=-0.84 and r=-0.63; P<0.0001). Lastly, regression analysis revealed a significant correlation between the changes in LA and MBF during CPT for patients with elevated CRP levels and those for patients with normal CRP levels (r=0.56 and r=0.66; P<0.001).
CONCLUSIONS: These findings suggest a direct association between systemic microinflammation and altered coronary vasomotor function of both the epicardial conductance and the arteriolar resistance vessels.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15313940     DOI: 10.1161/01.CIR.0000140264.56496.76

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  24 in total

1.  Early insights of cardiac risk and treatment response with quantitative PET monitoring of coronary-specific endothelial dysfunction and myocardial perfusion reserve.

Authors:  Ronald G Schwartz
Journal:  J Nucl Cardiol       Date:  2010-12       Impact factor: 5.952

2.  PET-measured heterogeneity in longitudinal myocardial blood flow in response to sympathetic and pharmacologic stress as a non-invasive probe of epicardial vasomotor dysfunction.

Authors:  Thomas H Schindler; Alvaro D Facta; John O Prior; Roxana Campisi; Masayuki Inubushi; Michael C Kreissl; Xiao-Li Zhang; James Sayre; Magnus Dahlbom; Heinrich R Schelbert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-26       Impact factor: 9.236

Review 3.  Role of PET in the evaluation and understanding of coronary physiology.

Authors:  Thomas H Schindler; Xiao-Li Zhang; Gabriella Vincenti; Leila Mhiri; René Lerch; Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

4.  Diagnostic value of PET-measured heterogeneity in myocardial blood flows during cold pressor testing for the identification of coronary vasomotor dysfunction.

Authors:  Thomas H Schindler; Xiao-Li Zhang; Gabriella Vincenti; Leila Mhiri; Rene Nkoulou; Hanjoerg Just; Osman Ratib; Francois Mach; Magnus Dahlbom; Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2007 Sep-Oct       Impact factor: 5.952

Review 5.  Coronary vasomotor function assessed by positron emission tomography.

Authors:  Nagara Tamaki; Keiichiro Yoshinaga; Masanao Naya
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-11-24       Impact factor: 9.236

Review 6.  Platelet GP IIb-IIIa Receptor Antagonists in Primary Angioplasty: Back to the Future.

Authors:  Giuseppe De Luca; Stefano Savonitto; Arnoud W J van't Hof; Harry Suryapranata
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

7.  Impaired coronary and retinal vasomotor function to hyperoxia in Individuals with Type 2 diabetes.

Authors:  Mary E Lott; Julia E Slocomb; Zhaohui Gao; Robert A Gabbay; David Quillen; Thomas W Gardner; Kerstin Bettermann
Journal:  Microvasc Res       Date:  2015-05-20       Impact factor: 3.514

Review 8.  The influence of insulin resistance, obesity, and diabetes mellitus on vascular tone and myocardial blood flow.

Authors:  Ines Valenta; Vasken Dilsizian; Alessandra Quercioli; Heinrich R Schelbert; Thomas H Schindler
Journal:  Curr Cardiol Rep       Date:  2012-04       Impact factor: 2.931

Review 9.  Cardiac PET perfusion tracers: current status and future directions.

Authors:  Jamshid Maddahi; René R S Packard
Journal:  Semin Nucl Med       Date:  2014-09       Impact factor: 4.446

10.  Acute phase proteins activation in subjects with coronary atherosclerosis and micro-vessel coronary circulation impairment.

Authors:  Natale Daniele Brunetti; Roberto Padalino; Luisa De Gennaro; Andrea Cuculo; Luigi Ziccardi; Pier Luigi Pellegrino; Matteo Di Biase
Journal:  J Thromb Thrombolysis       Date:  2008-08-09       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.